A federal jury in Trenton has found in favor of Merck & Co. Inc. in the first suit to go to trial over claims that its osteoporosis drug Fosamax causes fractured femurs.

After an hour and 20 minutes of deliberation on Monday, jurors voted 8 to 0 that the plaintiff failed to prove by a preponderance of the evidence that her fracture was of the so-called atypical type said to be caused by the drug.